Advertisement

5×5 CMOS capacitive sensor array for detection of the neurotransmitter dopamine.

17:55 EDT 23rd May 2013 | BioPortfolio

Summary of "5×5 CMOS capacitive sensor array for detection of the neurotransmitter dopamine."

This work presents miniaturized CMOS (complementary metal oxide semiconductor) capacitive sensors for detection of the neurotransmitter dopamine (DA) down to the sub-fM range. Sensing resolution is significantly enhanced by monolithic sensor integration to reduce the parasitic effect and the use of sub-μm interdigitated microelectrodes as the sensing interface. The 5×5 sensor array contains five designs of different electrode sizes and each design has five sensors. The positive charges produced from protonation of boronate and amino group after immobilization of 4-carboxyphenylboronic acid (CPBA) result in an increase of the electrode-analyte capacitance. Then the negative charges produced after binding of CPBA and DA molecules decrease the electrode-analyte capacitance. Signal transduction is achieved through a CMOS readout circuit whose output frequency is inversely proportional to the capacitance. Experimental results showed the ratios of average percentage capacitance changes of the experiment groups over those of the control groups were all larger than one for the five designs at DA concentration of 0.1fM. Selectivity against the non-analyte species, such as tyramine, has also been demonstrated.

Affiliation

Department of Electrical Engineering, National Tsing Hua University, Hsinchu 300, Taiwan, ROC; Institute of Electronics Engineering, National Tsing Hua University, Hsinchu 300, Taiwan, ROC; Institute of NanoEngineering and Microsystems, National Tsing Hua

Journal Details

This article was published in the following journal.

Name: Biosensors & bioelectronics
ISSN: 1873-4235
Pages:

Links

Medical and Biotech [MESH] Definitions

Dopamine Plasma Membrane Transport Proteins

Sodium chloride-dependent neurotransmitter symporters located primarily on the PLASMA MEMBRANE of dopaminergic neurons. They remove DOPAMINE from the EXTRACELLULAR SPACE by high affinity reuptake into PRESYNAPTIC TERMINALS and are the target of DOPAMINE UPTAKE INHIBITORS.

Receptors, Dopamine D2

A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D2-class receptor genes contain INTRONS, and the receptors inhibit ADENYLATE CYCLASE.

Receptors, Dopamine D1

A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D1-class receptor genes lack INTRONS, and the receptors stimulate ADENYLATE CYCLASE.

Substantia Nigra

The black substance in the ventral midbrain or the nucleus of cells containing the black substance. These cells produce DOPAMINE, an important neurotransmitter in regulation of the sensorimotor system and mood. The dark colored MELANIN is a by-product of dopamine synthesis.

Dopamine Antagonists

Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME.

PubMed Articles [ 12544 Associated PubMed Articles listed on BioPortfolio]

Carbon nanofiber electrode array for electrochemical detection of dopamine using fast scan cyclic voltammetry.

A carbon nanofiber (CNF) electrode array was integrated with the Wireless Instantaneous Neurotransmitter Concentration Sensor System (WINCS) for the detection of dopamine using fast scan cyclic voltam...

CMOS image sensor for detection of interferon gamma protein interaction as a point-of-care approach.

Complementary metal oxide semiconductor (CMOS)-based image sensors have received increased attention owing to the possibility of incorporating them into portable diagnostic devices. The present resear...

Rapid, sensitive, and multiplexed on-chip optical sensors for micro-gas chromatography.

We developed and characterized a rapid, sensitive and integrated optical vapor sensor array for micro-gas chromatography (μGC) applications. The sensor is based on the Fabry-Pérot (FP) interferomete...

A Functional Hybrid Memristor Crossbar-Array/CMOS System for Data Storage and Neuromorphic Applications.

Crossbar arrays based on two-terminal resistive switches have been proposed as a leading candidate for future memory and logic applications. Here we demonstrate a high-density, fully operational hybri...

Spirally oriented Au microelectrode array sensor for detection of Hg (II).

A simple and reproducible carbon microelectrode array (CMA), designed to eliminate diffusive interference among the microelectrodes, has been fabricated and used as a frame to build a gold (Au) microe...

Clinical Trials [ 866 Associated Clinical Trials listed on BioPortfolio]

An Inpatient Evaluation of Six-Day Subcutaneous Glucose Sensor Performance

The purpose of this study is to assess the performance of the subcutaneous glucose sensor over an extended sensor life. The sensor is currently approved for 3 days of use and this study wi...

New Glucose Sensor Pediatric

The purpose of this study is to assess performance of a new subcutaneous glucose sensor over a seven day sensor life when used with currently marketed Medtronic Diabetes devices. In additi...

Neuroimaging of Dopamine Metabolism in Normal and Psychiatric Patients

Brain cells communicate with each other by releasing chemicals called neurotransmitters. In order for brain cells to transfer information, one cell will release a neurotransmitter that wi...

Treatment of Parkinson's Disease With a Transdermal Skin Patch

Patients with Parkinson's disease are missing the chemical neurotransmitter dopamine. This occurs as a result of destructive changes in an area of the brain responsible for making dopamin...

Treatment of Parkinson's Disease With Eliprodil

Patients with Parkinson's disease are missing the chemical neurotransmitter dopamine. This occurs as a result of destructive changes in an area of the brain responsible for making dopamin...

Search BioPortfolio: